title: Reply: Increased Mortality during Bleomycin-induced Pulmonary Fibrosis due to Low Endogenous Activated Protein C Levels.
authors.affiliation: 1 CHU Montpellier Montpellier, France.|2 INSERM U1046 Montpellier, France.
authors.forename: Khuder
authors.initials: K
authors.lastname: Alagha
authors.affiliation: 1 CHU Montpellier Montpellier, France.|2 INSERM U1046 Montpellier, France.
authors.forename: Arnaud
authors.initials: A
authors.lastname: Bourdin
authors.affiliation: 3 APHM Marseille, France and.|4 INSERM UMR1067 Marseille, France.
authors.forename: Pascal
authors.initials: P
authors.lastname: Chanez
mesh_terms: D001281:Atrial Fibrillation / Q000150:complications* / Q000188:drug therapy*; D006801:Humans; D054990:Idiopathic Pulmonary Fibrosis / Q000150:complications*; D008297:Male; D013924:Thrombophlebitis / Q000150:complications* / Q000188:drug therapy*; D014859:Warfarin / Q000009:adverse effects*
chemical_list: D014859:Warfarin